What will the FDA's decision be on Brepocitinib by Priovant Therapeutics in 2026?
🗂 Part of event: FDA decision: Brepocitinib by Priovant Therapeutics (in 2026) →💡 What the odds say
The market puts this at about a 98% chance — almost certain.
No money — just record your call and see if you were right. Yes is at 98% right now.
Data from Kalshi’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
Loading…
How it resolves
Settled by Kalshi, a CFTC-regulated US exchange, against the official source named in each contract (e.g. a government release or election certification), with an Outcome Review Committee as a backstop for disputes.
Resolution criteria
If the FDA's decision on Brepocitinib by Priovant Therapeutics in 2026 is a full approval or an accelerated approval, the market resolves to Yes.
ⓘ A market settles under its own written rules, which can lag what looks decided in the news — so the price may not move to 100% the moment an outcome seems obvious.
View the official rules on Kalshi ↗Related markets
Next target for the US interest rate (July)
4 outcomes
Number of FOMC meetings with FED interest rate cuts in the US in 2026
7 outcomes